Literature DB >> 1111443

Occult breast carcinomas detected by xeroradiography: clinical considerations.

L J Malone, G Frankl, R A Dorazio, J H Winkley.   

Abstract

One hundred and eighty-five breast cancers were demonstrated by xeroradiography in 6,238 patients. Sixty-two cancers were occult, and constituted one-third of the demonstrable breast cancers. Some of the patients with clinically nonpalpable carcinomas had high risk factors known to be associated with the development of breast cancer. The diagnosis was usually established and confirmed by wide excisional biopsy of the area containing the suspicious lesion. In some instances the lesion was localized preoperatively by xeroradiography using a technique of skin markings. Specimen xeroradiography was utilized if there were calcifications seen on the preoperative xeroradiograph. There was a significantly decreased incidence of axillary node metastases in the occult cases when compared to the dominant mass cases.

Entities:  

Mesh:

Year:  1975        PMID: 1111443      PMCID: PMC1343741          DOI: 10.1097/00000658-197502000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  3 in total

1.  Breast xeroradiography: an analysis of our first 17 months.

Authors:  G Frankl; D D Rosenfeld
Journal:  Ann Surg       Date:  1973-11       Impact factor: 12.969

2.  Xeromammography--an improved diagnostic method. A review of 250 biopsied cases.

Authors:  J E Martin
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1973-01

3.  Cancer of the breast: size of neoplasm and prognosis.

Authors:  B Fisher; N H Slack; I D Bross
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

  3 in total
  3 in total

1.  Breast mass.

Authors:  C W Merrick; H C Press
Journal:  J Natl Med Assoc       Date:  1979-04       Impact factor: 1.798

2.  The surgeon's problem with breast cancer screening programs.

Authors:  R E Synder
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

3.  Back-up for screening for breast cancer.

Authors: 
Journal:  Br Med J       Date:  1978-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.